Galactosemia is a rare genetic metabolic disorder that affects an individual's ability to

metabolize the sugar galactose properly. Galactosemia is sometimes confused with Lactose-
Intolerance, but unlike lactose-intolerance, galactosemia is not something that someone can
"grow out of." Once diagnosed, it is there for the rest of the person's life.
Goppert first described the disease in 1917,[1] with its cause as a defect in galactose metabolism
being identified by a group led by Herman Kalckar in 1956.[2]
Its incidence is about 1 per 60,000 births (classic type). It is much rarer in Japan and much more
common in Italy, specifically the traveler region. Galactosemia is also very common within the
Irish Traveller population. This is attributed to consanguinity within a relatively small gene pool.
[citation needed]

Cause

Axial hydroxyl group drawn in red.

Lactose Glucose
Lactose in food (such as dairy products) is broken down by the enzyme lactase into glucose and
galactose. In individuals with galactosemia, the enzymes needed for further metabolism of
galactose are severely diminished or missing entirely, leading to toxic levels of galactose in the
blood, resulting in hepatomegaly (an enlarged liver), cirrhosis, renal failure, cataracts, brain
damage, and ovarian failure. Without treatment, mortality in infants with galactosemia is about
75%.
[edit] Types
Galactose is converted into glucose by the action of three enzymes, known as the Leloir
pathway. Accordingly, there are 3 known types of Galactosemia; type 1, 2 and 3:

Diseases
Type OMIM Gene Locus Enzyme Name
Database

galactose-1-
Type
5056 230400 GALT 9p13 phosphate uridyl classic galactosemia
1
transferase
Type GALK
29829 230200 17q24 galactokinase galactokinase deficiency
2 1

galactose epimerase
Type 1p36- UDP galactose
29842 230350 GALE deficiency, UDP-Galactose-
3 p35 epimerase
4-epimerase deficiency

The order of these three types is not the same as the order that the enzymes are encountered by
galactose on its metabolic path (which is closer to GALK, GALT, and then GALE, though many
variations can occur.)
Diagnosis
Infants are now routinely screened for galactosemia in the United States, and the diagnosis is
made while the person is still an infant. Infants affected by galactosemia typically present with
symptoms of lethargy, vomiting, diarrhea, failure to thrive, and jaundice. None of these
symptoms are specific to galactosemia, often leading to diagnostic delays. Luckily, most infants
are diagnosed on newborn screening. A galactosemia test is a blood test (from the heel of the
infant) or urine test that checks for three enzymes that are needed to change galactose-a sugar
that is found in milk and milk products-into glucose, a sugar that your body uses for energy. A
person with galactosemia doesn't have one of these enzymes. This causes high levels of galactose
in the blood or urine.
Galactosemia is normally first detected through newborn screening, or NBS. Affected children
can have serious, irreversible effects or even die within days from birth. It is important that
newborns be screened for metabolic disorders without delay. Galactosemia can even be detected
through NBS before any ingestion of galactose containing formula or breast milk.
Detection of the disorder through newborn screening (NBS) does not depend on protein or
lactose ingestion, and, therefore, it should be identified on the first specimen unless the infant has
been transfused. A specimen should be taken prior to transfusion. The enzyme is prone to
damage if the sample is delayed in the mail or exposed to high temperatures. The routine NBS is
accurate for detection of galactosemia. Two screening tests are used to screen infants affected
with galactosemia - the Beutler's test and the Hill test. In fact a third test, called the "Florida
test", is also normally performed on all galactosemia positives. The Beutler's test screens for
galactosemia by detecting the level of enzyme of the infant. Therefore, the ingestion of formula
or breast milk does not effect the outcome of this part of the NBS, and the NBS is accurate for
detecting galactosemia prior to any ingestion of galactose.
Treatment
The only treatment for classic galactosemia is eliminating lactose and galactose from the diet.
Even with an early diagnosis and a restricted diet, however, some individuals with galactosemia
experience long-term complications such as speech difficulties, learning disabilities, neurological
impairment (e.g. tremors, etc), and in girls, ovarian failure. These complications are treated if
they appear in a manner similar to the way they would be treated in a non-galactosemic. Such
complications have not been associated with Duarte galactosemia, and many individuals with
Duarte galactosemia do not need to restrict their diet at all. Infants with classic galactosemia
cannot be breast-fed due to lactose in human breast milk and are usually fed a soy-based
formula.[3]
Galactosemia is sometimes confused with lactose intolerance, but galactosemia is a more serious
condition. Lactose intolerant individuals have an acquired or inherited shortage of the enzyme
lactase, and experience abdominal pains after ingesting dairy products, but no long-term effects.
In contrast, a galactosemic individual who consumes galactose can cause permanent damage to
their bodies.
Long term complication of galactosemia includes:
• Speech deficits
• Ataxia
• Dysmetria
• Diminished bone density
• Premature ovarian failure
• Cataract